𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytogenetic alterations in nonmelanoma skin cancer: A review

✍ Scribed by Kevin J. Ashton; Melanie A. Carless; Lyn R. Griffiths


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
126 KB
Volume
43
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Since the advent of cytogenetic analysis, knowledge about fundamental aspects of cancer biology has increased, allowing the processes of cancer development and progression to be more fully understood and appreciated. Classical cytogenetic analysis of solid tumors had been considered difficult, but new advances in culturing techniques and the addition of new cytogenetic technologies have enabled a more comprehensive analysis of chromosomal aberrations associated with solid tumors. Our purpose in this review is to discuss the cytogenetic findings on a number of nonmelanoma skin cancers, including squamous‐ and basal cell carcinomas, keratoacanthoma, squamous cell carcinoma in situ (Bowen's disease), and solar keratosis. Through classical cytogenetic techniques, as well as fluorescence‐based techniques such as fluorescence in situ hybridization and comparative genomic hybridization, numerous chromosomal alterations have been identified. These aberrations may aid in further defining the stages and classifications of nonmelanoma skin cancer and also may implicate chromosomal regions involved in progression and metastatic potential. This information, along with the development of newer technologies (including laser capture microdissection and comparative genomic hybridization arrays) that allow for more refined analysis, will continue to increase our knowledge about the role of chromosomal events at all stages of cancer development and progression and, more specifically, about how they are associated with nonmelanoma skin cancer. Β© 2005 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Nonmelanoma skin cancer in inflammatory
✍ Millie D. Long; Michael D. Kappelman; Clare A. Pipkin πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 82 KB πŸ‘ 2 views

At least 1 million new cases of nonmelanoma skin cancer (NMSC) are diagnosed in the United States each year and the incidence is increasing. A higher incidence of NMSC in organ transplant recipients on immunosuppression has been documented for some time, and recent studies indicate that patients wit

In vivo nonmelanoma skin cancer diagnosi
✍ Chad A. Lieber; Shovan K. Majumder; Darrel L. Ellis; D. Dean Billheimer; Anita M πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

## Abstract ## Background and Objectives Nonmelanoma skin cancers, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are the most common skin cancers, presenting nearly as many cases as all other cancers combined. The current gold‐standard for clinical diagnosis of these lesi

Effect of NSAIDs on the recurrence of no
✍ Maria V. Grau; John A. Baron; Bryan Langholz; Margaret Karagas; E. Robert Greenb πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 91 KB πŸ‘ 1 views

## Abstract Experimental studies have consistently shown a protective effect of nonsteroidal antiinflammatory drugs (NSAIDs) against nonmelanoma skin cancers (NMSC). However, little human epidemiological research has been done in this regard. We used data from the Skin Cancer Chemoprevention Study